|
As Executive Vice President of Strategic Development, Sanjay Sabnani oversees Hythiam�s intellectual property, scientific and corporate communications, and technology acquisition. Sabnani has a strong background in introducing innovative technologies to specialist markets. Sabnani is the co-author of Benzodiazepines and Other Sedative-Hypnotics in the forthcoming 4th edition of the American Psychiatric Association�s Textbook of Substance Abuse Treatment. He has also authored articles for publications such as the Los Angeles Business Journal. Sabnani graduated from the University of California in Los Angeles. | 